Lead Product(s) : Bacillus Coagulans
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Undisclosed
Sponsor : TCI Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLD
Details : Bacillus Coagulans is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Non-alcoholic Fatty Liver Disease.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
December 02, 2022
Lead Product(s) : Bacillus Coagulans
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Undisclosed
Sponsor : TCI Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable